Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders.
about
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's diseaseInsight into the Molecular Imaging of Alzheimer's DiseaseHeat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseasesImplications of glial nitric oxide in neurodegenerative diseasesFerulic Acid: A Hope for Alzheimer's Disease Therapy from PlantsOsteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodelingNextGen Brain Microdialysis: Applying Modern Metabolomics Technology to the Analysis of Extracellular Fluid in the Central Nervous System.Lessons from Microglia Aging for the Link between Inflammatory Bone Disorders and Alzheimer's DiseaseCellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disordersMitochondrial dysfunction increases allergic airway inflammationIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesAnti-Inflammatory and Anti-Nociceptive Activities of Stem-Bark Extracts and Fractions of Carpolobia Lutea (Polygalaceae)Isolation, characterization and hypolipidemic activity of ferulic acid in high-fat-diet-induced hyperlipidemia in laboratory ratsTowards understanding brain-gut-microbiome connections in Alzheimer's diseaseVanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice.Mood, memory and movement: an age-related neurodegenerative complex?Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.Chronic sleep fragmentation during the sleep period induces hypothalamic endoplasmic reticulum stress and PTP1b-mediated leptin resistance in male mice.Cadmium-Induced Disruption in 24-h Expression of Clock and Redox Enzyme Genes in Rat Medial Basal Hypothalamus: Prevention by MelatoninAmyloid beta-protein assembly and Alzheimer disease.Dairy intake is associated with brain glutathione concentration in older adults.Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.PiZ mouse liver accumulates polyubiquitin conjugates that associate with catalytically active 26S proteasomesThe "Alzheimer's disease signature": potential perspectives for novel biomarkers.Protective Effect of Total Phenolic Compounds from Inula helenium on Hydrogen Peroxide-induced Oxidative Stress in SH-SY5Y Cells.Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In VivoInvolvement of Heme Oxygenase-1 Induction in the Cytoprotective and Immunomodulatory Activities of Viola patrinii in Murine Hippocampal and Microglia Cells.Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.Mitochondria impairment correlates with increased sensitivity of aging RPE cells to oxidative stress.Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cellsOxidative stress and cellular stress response in diabetic nephropathy.Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cellsOgg1 null mice exhibit age-associated loss of the nigrostriatal pathway and increased sensitivity to MPTP.
P2860
Q21091189-B8D770A1-91E0-4F67-9A12-94ABA3901DDAQ26765945-37C54369-4745-486D-936C-8F9619CBB689Q26778791-548CF2BD-7588-44E4-A48B-EE7277062ABBQ26782894-948AB9CB-A829-47BA-A998-64B7127A5FD5Q26799917-F21F83FC-B854-4549-A25F-A9E765E6A28CQ27000195-B8EC5030-C906-420B-A6EF-94B3F0AA74B9Q27343265-CFB4C9A2-8F4A-4EB6-9936-B3F2FF87E8A2Q28085613-BC791380-DA08-43A8-A2D9-936D5686B683Q28384232-5795978A-D3F2-4A0F-B7ED-C760AE7247F0Q28385941-2B31AF6A-7EC2-4B5A-B878-3DED1386A581Q28388335-1C3B1258-EF10-4A7D-AA3B-8C997571F0E4Q28468477-C5F8F62D-2F49-419A-8732-354101F147C8Q28817575-D54E1305-CCC1-4EDB-B376-3DE6FAE658A7Q28831443-CE3B1AAF-49DC-42A5-86CD-75BD8D8D3DE7Q30835280-5E18555B-281E-452B-AB98-29B54B27628AQ33554878-0628BF2B-B2DC-4006-98A8-724A205697EFQ33569173-FF910696-57BD-4E5B-A4C6-93D61851BC16Q33860500-5A49D5F6-3968-47DB-9854-15E0048FDF01Q34094516-5CD2A8D6-85D1-4777-982B-5E57E3B33BACQ34556705-5E2B3E66-7ED6-423D-B0BB-0748B70E21B2Q34590312-73487707-95A2-4E66-8CA8-44B027587A20Q34676296-30D56A7C-E3A6-4638-B1F5-7C2552CEA8E7Q34707881-88AB18CB-01FF-4BF9-B420-8A7403084DCCQ34849544-82E3510B-EF74-4AEF-BB64-FB4EDEBEB6F4Q35016254-BAFCC210-7F8D-4630-B634-8F68F9DACB7BQ35231770-CA54C409-3A95-4E4A-A146-62888083F359Q35247414-8E1930DA-2881-4FE9-A4C4-04620472DA3FQ35339326-AC00F42F-FC6F-44B8-88F9-EC34B9E05F16Q35640943-3134E1B4-C6D8-4E9A-AF9F-DE542E22AC57Q35725793-073D347D-5C57-4DFB-AFE6-C8B337BE6902Q35830378-4EBEB4B7-6B47-40E4-84B3-24BEEA3A15A9Q35872370-97A0C8CF-3F31-4B58-AB2E-45D8E372801BQ35942562-C872CC6E-B4ED-44E4-8340-508EE0DA8B3DQ36024307-B1420402-3874-4738-87C5-21FB1B2EDD1AQ36041047-85004814-0DB8-4857-923B-0BB3A6D0CC12Q36067322-57AA3691-4497-406C-B4B0-3BAEFE37E4EEQ36144019-D7F747E7-422C-4173-B034-C5C0EA19D205Q36259336-28FB6011-F578-4069-B05F-48C9EABAF4C6Q36275187-5478851E-3D5E-4093-83F8-DCD582F5673BQ36309964-4080E7CE-423D-49DB-B5C9-782A19E05E74
P2860
Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mitochondrial dysfunction, fre ...... n neurodegenerative disorders.
@ast
Mitochondrial dysfunction, fre ...... n neurodegenerative disorders.
@en
type
label
Mitochondrial dysfunction, fre ...... n neurodegenerative disorders.
@ast
Mitochondrial dysfunction, fre ...... n neurodegenerative disorders.
@en
prefLabel
Mitochondrial dysfunction, fre ...... n neurodegenerative disorders.
@ast
Mitochondrial dysfunction, fre ...... n neurodegenerative disorders.
@en
P2093
P356
P1476
Mitochondrial dysfunction, fre ...... n neurodegenerative disorders.
@en
P2093
Anna Maria Giuffrida Stella
Carlo De Marco
Cesare Mancuso
Diego Currò
Giovanni Scapagini
Vittorio Calabrese
P304
P356
10.2741/2130
P577
2007-01-01T00:00:00Z